Evidence map›Paper›PMID 35127304›Full record

Article3 Biotech2022

Chemical investigation and screening of anti-cancer potential of

Atena Vafaei Malek Abadi, Ehsan Karimi, Ehsan Oskoueian, Ghasem Rahimi Kalateh Shah Mohammad, Negin Shafaei

Abstract read
In one paragraph

Article in 3 Biotech, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Evaluating the multifaceted bioactivity ofTurkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  6. In Vitro and In Silico Evaluation ofPlants (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Antimicrobial, Antibiofilm, and Anticancer Activities ofMolecules (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Anticancer of genusExploration of targeted anti-tumor therapy · 2023
    Review
  13. Review
  14. Review
  15. Apple pectin-basedFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Atena Vafaei Malek AbadiDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Ehsan KarimiDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.ORCID 0000-0002-5011-9611
Ehsan OskoueianDepartment of Research and Development, Arka Industrial Cluster, Mashhad, Iran.
Ghasem Rahimi Kalateh Shah MohammadDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Negin ShafaeiDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was done to improve the medicinal properties of

Indexed as

Anti-cancerApoptotic activitySyzygium aromaticum L. bud essential oil nanoemulsion (SABE-NE)

Identifiers

PMID35127304
PMCPMC8795257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.